Member Info for JRDC

Apparently an 11 hour drive to Moscow, depending on what resistance they might meet. Internet is being switched off in Moscow,. Reports Belarusian president might have gone on his private plane to a bunker in Russia

Can't sleep with all the excitement going on in Russia. Heavy armed vehicles setting up checkpoints in Moscow, and this.

Prigozhin: “At the moment we have crossed the state border in all places. The border guards came out to meet and hugged our soldiers.

Now we are entering Rostov. The conscripts, who were thrown to block our road, stepped aside. We don't fight children. Shoigu kills children.

But if someone gets in the way, we will destroy everything that gets in the way . We reach out to everyone. No need to spit in this hand.

We go on, we go to the end.

As for "statements about arrests. This is brotherhood, this is justice, this is honor, this is conscience, what we have. And when you make statements, you do not have these feelings. Therefore, you cannot understand anything but betrayal."

last time there was rumour of a fund raise, the usual rampers called it out to be a load of ****** and abused anyone who disagreed. luckily the fund raise turned out to be positive for the sp so they saved face.

given the dodgy fall in sp recently i wouldn't be surprised to see another raise. cash will need to come from somewhere for phase 2. however, it raises a few questions. why why the hell spaff all that cash on acquisitions when precision should be the sole focus.

what commercial interest is there in licencing precision or affimer platform? i'm guessing **** all currently otherwise they'd wait. follow up question, are avacta surprised at lack of interest this far in to 1a, or are potential suitors waiting for p1b results? does our licence agreement with tufts have prohibitive terms, maybe they used the same lawyers as novacyt and signed it on a friday afternoon? is the issue that the patents will expire before drugs will reach market and only avacta themselves could extend them?

hoping none of the above is true and agm will put sh minds at ease, but given track record so far the line between over extending themselves and incompetence is becoming blurred. been here 3 years, happy to wait another 3

Given this Car-t therapy is at least 5-7 years away from market even if trials go swimmingly, whats another 90 days or so?

Must admit, I've never seen a share where a senior exec or director has sold, regardless of amount, and then SP shoots up with 4-5 weeks. One for the bottom drawer.

GDR will still exist in July 24, novacyt might not if they lose the dispute.

Well done for jinxing it. I was dangerously close to break even just 0.25p off, now we're back to form

Exactly itsawrap. Those ignoring that are at best completely naive and should stick to fixed rate savers, or at worst trying to draw new mugs in to investing in the Nova roulette wheel so they can get out.

What an absolutely horrific update. £25m loss. And the worst part is we're due another one before the court case next June. Could well be 20p by then, and on the outside chance Nova win the case, the market knows it won't be long till the rest of the cash is pi55ed away so at best it'll go back to a quid. Shocking incompetence.

They'd be better off sacking all the board, staff, assets like buildings and IPR, and just spread what little cash is left across savings accounts paying 3.5%+. Can be run by an accountant, and then just pay dividends of 3.4%

I see that the majority of applications so far have been rejected for the trial. I presume these are from people self referring for that last bit of hope rather than referred from a clinician who has matched up trial requirements versus the patients best interests. Quite a sad thought to start the day

Could do what THG did yesterday, make up some vague story about avacta bring in talks with a major pharma and then ask al to confirm or refute and see where we're at.

I wonder... if 3996 could be made tumour agnostic, can it be combined with 6000 as a sort of super drug? Would combining the two in to one drug increase potential patent length?

Presention notes leaked online.

Ow do. Ah'm Alan. Thank theur for comin t' presention, wi've summa' we 'ope tha'il enjoy. I got face on cos ot share price, burrit bloody werks. I'll hand over t' Fi, ah'm off for breadcake, take it away duck.

Not surprised tbh.

If you saw two people, one puts their entire £100m fortune on red on a roulette wheel for a single spin, the other just spins the roulette wheel but only makes minimum wage, who is the safer option?

Some big director buys would be nice, but it seems they'd rather play it safe too given they could be out of work in 18 months.

Board can't spend it, would be seen as deliberate deprivation of funds, they'll have been told they cannot spend anything above usual day to day operations, certainly no more acquisitions or share buy backs.

Just a case of waiting will June 24, and make a decision whether to stick more money in to average down enough to see some profit if the court case is favourable and counter case is also upheld, balanced with chucking money down the drain it they lose or have to settle at detrimental terms.

You misheard WBA, GM said we're developing in to a big crap company.

If avacta moves to nasdaq, what happens to our shares? Do they just transfer over, or are they sold at market price before being made available for purchase again? Is there potential CGT liability if outside SIPP or ISA?

Basically, can us shareholders be shafted if they move?

I once saw him kill three patients in a waiting room... with an affimer, with a furkin affimer

In my mind given nothing quantified so far, therapeutic dose = amount of dox you'd expect in a tumour if given a standard session of dox based Chemo. So, it's already great news, as we're not seeing the associated cardiotoxicity.

I think what Al is looking for now, is order of magnitudes greater presence of dox in the tumour, to show an unprecedented amount of tumour killing chemicals can be made safe. Will absolutely blow the doors off the thing, this can be the only reason for further DE, to show there's nothing else on the planet that can do what pre cision can do. He's showed it works even better than in the lab, now we're at the show boating stage, and he's decided the financial hit and 6-12 month delay is worth it in the long run. I can't argue with that.

All these concerned posters are hilarious, they're absolutely ****ed if they have a short in place.

I think it's a combination of that the market works on facts, we're pretty damn confident that 1b is a formality, proving efficacy, Mr market wants this clinically proven, 2nd part is phase 2 funding. We're hopeful it'll be through licencing 3996 or other candidate from the precision platform, and imo its the most likely, but Mr market according to statistics of thinks a further fund raise might occur.

The difference between Mr Market and the majority of LTH is we have done the research to base our investment decisions and 1a has shown its better than we imagined, they rely on a computer to do it for them.

Either way, I hope its still this price come early Feb when my next pension payment goes in, I feel like I'm robbing someone. Whatever happens, and however they decide to fund things over next few years, this is only going one way. Roll on science day, maybe then we'll see some (inter) national news interest.